ARCHIVES

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of July

July 26, 2013

L-PAM, Less Than Radical Surgery Results Holding Up, New Breast Cancer Studies Sought

September 12, 1975

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care

November 1, 2013

DCCR Merit Review Of Contracts Finds Most Perform Satisfactorily; 21 Phased Out Early

January 5, 1979

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

May 30, 1975